News
-
-
-
PRESS RELEASE
Update of the financial calendar: publication of half-year results before October 10, 2026
Exail Technologies postpones the publication of its first half 2026 results to October 10, 2026 due to complex financial instruments accounting reassessment, no impact on previously released financial figures or operational momentum -
-
-
PRESS RELEASE
Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset
Amoéba transitions to an industrial biocontrol company, targets €40 million revenue by 2030. Monetizes Willa™ cosmetics asset. Provisional 2026 financial results revealed -
-
-
-
REGULATED PRESS RELEASE
Financial statements - 30 june 2026